References/Publications for Western/Immunoblot of Alt a 7

Check all              

Select PubMed ID Description
7898496
Mol Immunol. 1995 Feb;32(3):213-27.

Molecular cloning of major and minor allergens of Alternaria alternata and
Cladosporium herbarum.

Achatz G(1), Oberkofler H, Lechenauer E, Simon B, Unger A, Kandler D, Ebner C,
Prillinger H, Kraft D, Breitenbach M.


9095236 Adv Exp Med Biol. 1996;409:157-61.

Molecular characterization of Alternaria alternata and Cladosporium herbarum
allergens.

Achatz G(1), Oberkofler H, Lechenauer E, Simon B, Unger A, Kandler D, Ebner C,
Prillinger H, Kraft D, Breitenbach M.


9693275 Int Arch Allergy Immunol. 1998 Aug;116(4):261-8.

Molecular cloning of IgE-binding fragments of Alternaria alternata allergens.

De Vouge MW(1), Thaker AJ, Zhang L, Muradia G, Rode H, Vijay HM.


34829261 J Fungi (Basel). 2021 Nov 16;7(11). pii: 974. doi: 10.3390/jof7110974.

Changes in the Sensitization Pattern to Alternaria alternata Allergens in
Patients Treated with Alt a 1 Immunotherapy.

Rodríguez D(1), Tabar AI(2)(3), Castillo M(1), Martínez-Gomariz M(1), Dobski
IC(1), Palacios R(1).


4% of the patients recognized Alt a 1. The percentage of recognition for Alt
a 3, Alt a 4, and/or Alt a 6, Alt a 7, Alt a 8, Alt a 10 and/or Alt a 15 was
6%, 21.9%, 12.5%, 12.5%, and 12.5% respectively. Of the 64 patients, 45 (70.3%)
only recognized Alt a 1 among the allergens present in the A. alternata extract.
Immunotherapy with Alt a 1 desensitizes treated patients, reducing their symptoms
and medication consumption through the elimination of Alt a 1 sensitization,
which is no longer present in the immunoblotting of some patients. There may be
gender differences in the pattern of sensitization to A. alternata allergens,
among others.

DOI: 10.3390/jof7110974
PMCID: PMC8618185
PMID: 34829261